Ocean Biomedical, Inc. (OCEA)

Ocean Biomedical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	0	0.03	0.06	-
Cash & Short-Term Investments	-	0	0.03	0.06	-
Cash Growth	-	-88.23%	-43.33%	-	-
Prepaid Expenses	0.59	1.11	-	-	-
Restricted Cash	0.22	1	-	-	-
Other Current Assets	-	-	1.81	0.02	0.39
Total Current Assets	0.81	2.11	1.84	0.08	0.39
Long-Term Investments	0.09	3.39	-	-	-
Total Assets	0.9	5.5	1.84	0.08	0.39
Accounts Payable	0.8	0.93	-	0.24	0.05
Accrued Expenses	15.1	15.25	11.44	6.33	2.14
Short-Term Debt	16.9	13.06	1.22	0.18	0.08
Other Current Liabilities	1.09	0.76	-	-	-
Total Current Liabilities	33.89	30.01	12.66	6.74	2.27
Long-Term Debt	5.57	4.12	-	-	-
Other Long-Term Liabilities	59.06	62.13	-	-	-
Total Liabilities	98.52	96.26	12.66	6.74	2.27
Additional Paid-In Capital	107.92	105.29	70.77	57.57	-
Retained Earnings	-205.54	-196.06	-81.59	-64.23	-1.89
Shareholders' Equity	-97.62	-90.76	-10.82	-6.66	-1.89
Total Liabilities & Equity	0.9	5.5	1.84	0.08	0.39
Total Debt	22.47	17.19	1.22	0.18	0.08
Net Cash (Debt)	-22.47	-17.18	-1.19	-0.12	-0.08
Net Cash Per Share	-0.82	-0.65	-0.05	-0.01	-0.00
Filing Date Shares Outstanding	166.01	34.82	23.36	17.5	17.45
Total Common Shares Outstanding	34.87	34.65	23.36	17.5	17.45
Working Capital	-33.08	-27.9	-10.82	-6.66	-1.89
Book Value Per Share	-2.80	-2.62	-0.46	-0.38	-0.11
Tangible Book Value	-97.62	-90.76	-10.82	-6.66	-1.89
Tangible Book Value Per Share	-2.80	-2.62	-0.46	-0.38	-0.11

Source: S&P Global Market Intelligence. Standard template. Financial Sources.